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Gut microbiota modulation 
accounts for the neuroprotective 
properties of anthocyanins
Cláudia Marques1,2, Iva Fernandes  3, Manuela Meireles1,4, Ana Faria1,2,5, 
Jeremy P. E. Spencer6, Nuno Mateus3 & Conceição Calhau1,2
High-fat (HF) diets are thought to disrupt the profile of the gut microbiota in a manner that may 
contribute to the neuroinflammation and neurobehavioral changes observed in obesity. Accordingly, we 
hypothesize that by preventing HF-diet induced dysbiosis it is possible to prevent neuroinflammation 
and the consequent neurological disorders. Anthocyanins are flavonoids found in berries that 
exhibit anti-neuroinflammatory properties in the context of obesity. Here, we demonstrate that the 
blackberry anthocyanin-rich extract (BE) can modulate gut microbiota composition and counteract 
some of the features of HF-diet induced dysbiosis. In addition, we show that the modifications in gut 
microbial environment are partially linked with the anti-neuroinflammatory properties of BE. Through 
fecal metabolome analysis, we unravel the mechanism by which BE participates in the bilateral 
communication between the gut and the brain. BE alters host tryptophan metabolism, increasing 
the production of the neuroprotective metabolite kynurenic acid. These findings strongly suggest 
that dietary manipulation of the gut microbiota with anthocyanins can attenuate the neurologic 
complications of obesity, thus expanding the classification of psychobiotics to anthocyanins.
The incidence of neurodegenerative diseases, such as Alzheimer’s and Parkinson’s diseases has been increasing 
as global population gets older. The World Health Organization (WHO) predicts that by 2040, neurodegener-
ative diseases will overtake cancer to become the second leading cause of death after cardiovascular disease1. 
Accumulating evidence suggests that neurodegeneration occurs, in part, because the neuronal environment 
is disturbed in a cascade of processes collectively called neuroinflammation2. Neuroinflammation is also cen-
tral in other psychiatry disorders such as anxiety and depression which are often associated with obesity3,4. 
Neuroinflammatory processes are profoundly modulated by peripheral inflammatory stimuli, especially those 
coming from the gut microbiota5–7. In this regard, both central nervous system (CNS) and gut microbiota offer 
legitimate targets for novel therapeutic strategies aiming to treat the rising burden of neurodegenerative and 
neuropsychiatry disorders. Indeed, live microorganisms that produce a health benefit in patients suffering from 
psychiatric illness (psychobiotics) have been proposed as psychotropic drugs8. Recently, the definition of psycho-
biotics have been extended to also encompass prebiotics9.
Flavonoids are a class of polyphenolic compounds that have been proposed as novel agents capable of atten-
uating neurodegenerative pathology10. Data suggest that anthocyanins (often consumed in higher amounts than 
other flavonoids11) interact with neurons and microglia, facilitating synaptic connectivity under both normal and 
pathologic conditions12. In addition, as recently demonstrated, anthocyanins are able to attenuate the negative 
impact of high-fat (HF) diets on neuroinflammation13, although their precise mechanism of action is unclear. 
One possibility is that they may exert their effects through modulation of the gut microbiota14.
The aim of the present study was to test the hypothesis that anthocyanins modulate gut microbiota composi-
tion and prevent HF diet-induced dysbiosis. After confirming these assumptions and given the bilateral connec-
tivity that exists between gut and brain (the gut-brain axis)15,16, further investigations were carried out to study 
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whether the anti-neuroinflammatory properties of anthocyanins were related to the gut microbiota changes that 
these compounds bring about.
Results
Blackberry anthocyanin-rich extract (BE) modulate gut-microbiota composition and counteract 
some of the features of HF diet-induced dysbiosis. We compared the gut microbial community of 
Wistar rats fed either with standard (C) or high-fat (HF) diet and supplemented with BE by sequencing the 
V3-V4 regions of the 16S rRNA gene.
The gut microbiota of the animals was dominantly constituted by five phyla: Firmicutes, Bacteroidetes, 
Actinobacteria, Verrucomicrobia and Proteobacteria (Fig. 1A). The Firmicutes to Bacteroidetes ratio was signif-
icantly increased in HF diet groups (p > 0.05) (Fig. 1B).
Despite no differences observed at phylum level, at genus level, major differences were noted (Fig. 2A).
Results illustrated in Fig. 2A indicate the genus level distribution for the 4 diet groups. After 17 weeks of HF 
feeding, the profile of the gut microbiota of HF fed animals was significantly altered in comparison to the gut 
microbiota of control fed animals. Notably, bacteria belonging to the Firmicutes phylum such as Rumminococcus, 
Blautia, Erysipelatoclostridium, Streptococcus and Parasporobacterium were more abundant in HF fed animals 
(p < 0.05), whereas Lachnoclostridium, Pseudoflavonifractor, Oscillibacter and Anaerostipes (also Firmicutes) were 
more abundant in the animals of C group (p < 0.05) (Fig. 2A). In addition, HF diet decreased the abundance 
of Akkermansia, Prevotella and Paraeggerthella (p < 0.05), whereas it increased the abundance of Desulfovibrio, 
Rothia and Enterohabdus (p < 0.05) (Fig. 2A).
BE feeding induced several modifications in the gut microbiota composition of animals. Specifically, BE 
increased Pseudoflavonifractor when the animals were fed with C diet and increased Oscillobacter independently 
of the diet fat content (p < 0.05) (Fig. 2A). Moreover, BE struggled to recover the gut microbiota’s diversity when 
the animals were challenged with HF diet, as indicated by Shannon’s richness index (Fig. 2C).
To reduce the number of variables, a principal coordinate analysis (PCoA) was performed. The gut microbi-
ota communities from the four different groups (C, BE, HF and HFBE) were grouped into four different clusters 
(Fig. 2C). HF fed rats had a distinct gut microbiota that clustered separately from C and BE rats. Nevertheless, the 
gut microbiota communities of the HF + BE animals were also differentiated from those of HF rats (Fig. 2C). The 
reduction of Rumminococcus and the prevalence of Sporobacter were the main features that justified the segrega-
tion of HF + BE from HF group (Fig. 2D).
In summary, our data indicate that HF feeding strongly affected the composition of the gut microbiota and 
that BE can prevent some of the features of HF-diet induced dysbiosis (e.g. the increase of Rumminococcus and 
the decrease of Oscillobacter).
Changes in gut bacterial genera induced by BE are correlated with anti-neuroinflammatory 
properties. After characterizing the gut microbiota of the animals supplemented with BE, we sought to inves-
tigate if the protection against neuroinflammation, previously evaluated by our group, was associated with the 
changes observed in the gut bacterial genera of these animals.
Figure 1. (A) Major bacterial phyla in the gut microbiota of rats after 17 weeks of high-fat (HF) feeding and 
anthocyanin-rich blackberry extract (BE) supplementation. Bars represent the average of each phylum relative 
abundance in the 4 different diet groups. Each phylum is represented by a different color (n = 5–6 rats per 
group). (B) Firmicutes to Bacteroidetes ratio among groups. This ratio was calculated by dividing the number of 
copies of Firmicutes by the number of copies of Bacteroidetes quantified by real-time PCR. Values are expressed 
as mean ± SEM (n = 5–6 rats per group).
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In a previous work, we showed that BE consumption decreased TCK-1 expression in rat’s hippocam-
pus whereas fractalkine expression increased13. Here, we found that TCK-1 was negatively correlated with 
Pseudoflavonifractor and Sporobacter when the animals were fed with C and HF diet, respectively (p < 0.05) 
(Fig. 3A,B). Interestingly, these bacterial genera were those increased by BE in C and HF diet groups, respectively 
(Fig. 2A). However, fractalkine, a chemokine particularly important in the crosstalk between neurons and micro-
glia, was not correlated with any bacterial genus despite being upregulated in BE supplemented rat’s hippocampus 
(Fig. 3A,B).
BE modulate CNS inflammation via the microbial metabolites of tryptophan. As a component 
of the gram-negative bacteria and a trigger of the inflammatory response, lipopolysaccharide (LPS) was meas-
ured in the fecal samples of all animals. Although fecal LPS levels were not statistically different between groups 
(p > 0.05), a noticeable increase in LPS levels was observed in the fecal samples of the animals of HF diet group 
(Fig. 4). In contrast, in HF + BE animals, fecal LPS was similar to that measured in control fed animals, probably 
as a reflection of the gut microbiota modifications induced by BE (Fig. 4).
The liquid chromatography-mass spectrometry (LC-MS) analysis revealed the existence of additional com-
pounds in the animals’ fecal samples. Twenty-six compounds (with a maximum intensity above 1,000,000) were 
observed to be significantly altered between samples (p < 0.01) (Fig. 5). Tryptophan (one of the identified metab-
olites) was decreased in the groups supplemented with BE (p < 0.05, Fig. 5). Interestingly, fecal concentrations of 
tryptophan were positively correlated with TCK-1 expression in the hippocampus (r = 0.733, p < 0.05), indicating 
that changes in the gut bacterial genera prompted by BE could have altered host tryptophan metabolism. To verify 
this assumption, tryptophan and tryptophan metabolites (kynurenine and kynurenic acid) were searched in the 
Figure 2. Gut microbiota composition at the genus level among groups (n = 5–6 per group). (A) Relative 
abundance of gut bacterial genera. Bars represent the average of each genus relative abundance in the 4 different 
diet groups. Each genus is represented by a different color. (B) Shannon’s diversity index among groups. Values 
are expressed as mean ± SEM. (C) Gut bacterial genera were clustered using principal component analysis 
(PCoA). Results are plotted according to the first two principle components, which explain 36.8% (PC1) 
and 25.7% (PC2) of the variation in gut microbial composition (at genus level) between samples. Each point 
represents one sample and each diet group is denoted by a different color. Circles combine samples from the 
same diet group by their respective 95% confidence interval ellipse. (D) Heatmap and hierarchical clustering 
of the relative abundance of gut bacterial genera. Rows correspond to operational taxonomic units (OTUs) and 
columns represent the animals of the 4 different diet groups.
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urine of all animals. Tryptophan and kynurenic acid (Fig. 6) were increased in the urine of the animals fed with 
HF diet and supplemented with BE (p < 0.05), while kynurenine levels remained unchanged. On the contrary, no 
changes were observed in the animals of C + BE group.
Discussion
The present findings demonstrate for the first time that blackberry anthocyanins are able to prevent some of 
the features of HF diet-induced dysbiosis. In addition, we demonstrate that anthocyanin-induced changes in 
the gut microbiota composition are related with their anti-neuroinflammatory properties. Finally, we propose 
that anthocyanins are able to counteract diet-induced neuroinflammation through the stimulation of tryptophan 
metabolism along the kynurenine pathway.
A number of studies have shown that mental illness may have origins in the gut17–19. Indeed, compelled by 
the study of Bruce-Keller et al., we have already proposed that HF diet-induced dysbiosis could be the trigger of 
neuroinflammation, a common hallmark of neuropsychiatry disorders7.
Besides changing the gut microbiota composition (HF-diet induced dysbiosis), HF diets can also increase 
intestinal permeability, facilitating the passage of LPS into the circulation20. In addition, LPS transport from the 
intestine towards target tissues can also be enabled by the chylomicrons synthesized in response to fat feeding21. 
Figure 3. Heatmap of Spearman’s correlation test between gut bacterial genera and neuroinflammatory 
markers measured in hippocampus, (A) in the animals fed with standard diet (C and BE groups) and (B) 
in high-fat fed animals (HF and HFBE groups). Green color indicates a positive correlation while red color 
indicates a negative correlation. Squared cells represent correlations with statistical significance (p < 0.05).
Figure 4. Fecal LPS concentrations. Values are expressed as mean ± SEM (n = 5–6 rats per group).
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Once in circulation, LPS may activate CD14/TLR4 signaling in target tissues, including the brain and can also dis-
rupt the blood-brain barrier and induce neuroinflammation22. In our study, plasma LPS levels in animals fed with 
HF diet were not altered (data not shown), probably because the animals were fasted before sacrifice23. However, 
the propensity for increased fecal LPS levels may reflect the alterations in the gut microbiota composition that 
HF diet brought about and might be indicative of higher amounts of LPS in plasma. On the other hand, increased 
fecal LPS levels may activate dendritic cells within the intestinal barrier, increasing the production of cytokines 
and, thus contributing to peripheral and systemic inflammation24. In the present study, we evaluated whether 
anthocyanins were able to counteract these effects of HF diet.
Figure 5. (A) Metabolite features whose level varies significantly (p < 0.01) across groups are projected on 
the cloud plot depending on their retention time (x-axis) and m/z (y-axis). Statistical significance (p-value) is 
represented by the bubble’s color intensity. The size of the bubble denotes feature intensity (only features with 
maximum intensity above 1 000 000 are displayed). Feature assignments (p-value, m/z, RT) are displayed in 
a pop-up window for the identified metabolite tryptophan. (B) Extracted ion chromatogram (EIC) and (C) 
Boxplot of tryptophan. *p < 0.05 vs respective control.
Figure 6. (A) Tryptophan and tryptophan metabolites searched in the urine of the animals of all groups. (B) 
Boxplot of tryptophan and (C) Boxplot of kynurenic acid. *p < 0.05 vs respective control.
www.nature.com/scientificreports/
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The bioavailability of anthocyanins is considered to be low, therefore, it is expected that high amounts of these 
compounds reach the colon after consumption of anthocyanins-rich foods14. In fact, anthocyanins are extensively 
metabolized by the gut bacteria and these compounds can predominate during several days in the organism 
given the enterohepatic recirculation14,25. Concurrently, they are utilized by these microorganisms, and anthocy-
anins have been shown to selectively stimulate the growth of some bacterial groups14. Hidalgo et al. analyzed the 
effects of anthocyanins upon gut microbiota composition by real-time PCR, using batch culture fermentations. 
The authors showed that anthocyanins significantly enhanced the growth of Lactobacillus-Enterococcus spp and 
Bifidobacterium spp26. Here, we show for the first time a complete picture of the modulation of gut microbial gen-
era by blackberry anthocyanins, in a rodent model.
BE was able to prevent some of the features of HF-diet induced dysbiosis, including fecal LPS levels. In the 
context of a standard diet, BE increased Pseudoflavonifractor. Previously, Pseudoflavonifractor was found to 
be decreased in long-term users of proton pump inhibitors which have been associated with increased risk of 
Clostridium difficile infection27. In addition, it has been suggested that increases in Pseudoflavonifractor may 
increase the success of obese patients in losing weight consistently28. In the context of HF diet, BE increased 
Sporobacter similarly to Goji berries that ameliorated chronic colitis through the promotion of beneficial gut 
bacteria29.
After showing that BE modulates the gut microbiota composition and prevent some of the features of HF-diet 
induced dysbiosis, we demonstrated that BE-induced changes in gut microbiota profile were correlated with BE 
anti-neuroinflammatory properties, previously assessed on the hippocampus of the same animals. BE consump-
tion decreased TCK-1 expression in rat’s hippocampus whereas increased Pseudoflavonifractor and Sporobacter, 
in the context of C and HF diet, respectively. Although correlations do not always point towards causation, this 
reinforces the idea that BE protection against neuroinflammation can be due to gut microbiota modifications.
Besides LPS, other pathways may be involved in the bilateral communication between the gut and the brain30. 
Since tryptophan was decreased in the fecal samples of the animals supplemented with BE, we decided to explore 
the metabolic pathway of tryptophan. As a precursor of serotonin and kynurenine, changes in the supply and 
availability of this essential amino acid can have many implications for CNS functioning31. The dietary protein 
intake was the same in the groups supplemented with BE compared to the respective controls. Therefore, if tryp-
tophan was decreased in the fecal samples of the animals supplemented with BE, it could be because BE was 
stimulating either the microbial catabolism of tryptophan or the host tryptophan metabolism. Around 90% of 
tryptophan is metabolized by the kynurenine pathway32. In this regard, we looked for kynurenine and kynurenic 
acid (tryptophan metabolites produced along this pathway) in the urine of all animals. Interestingly, we found 
that tryptophan and kynurenic acid were increased in the HF + BE group. This result suggests that tryptophan 
is being converted in kynurenine and, in turn, kynurenine is being converted into kynurenic acid which may 
act as an antagonist at excitatory amino acid receptors and has been implicated in major psychiatric diseases33. 
Alterations in the gut microbial composition might result in changes in serum and urine kynurenic acid levels 
and could thus modify CNS excitation and behavior30. Some studies have also reported the anti-inflammatory 
properties of kynurenic acid34,35.
The increased production in kynurenic acid could explain, at least in part, the anti-neuroinflammatory prop-
erties of anthocyanins, especially in the context of HF diet.
Furthermore, tryptophan could be also be utilized in serotonin synthesis in the gut36 or for indole production 
by gut bacteria which has been shown to increase intestinal barrier integrity37.
Nevertheless, a direct role of anthocyanins in the brain should not be ruled out. Anthocyanin metabolites 
can accumulate in the brain and exert their effects directly, including the stimulation of fractalkine secretion12,38.
In conclusion, anthocyanins alter host tryptophan metabolism, generating metabolites responsible for the 
control of CNS inflammation. This might be a possible mechanism behind their anti-neuroinflammatory prop-
erties. Anthocyanins may act, therefore, as mediators of the microbiota-gut-brain axis, allowing the control of 
neuroinflammation by gut microbiota modulation.
These results strongly suggest that dietary manipulation of the gut microbiota by anthocyanins could attenuate 
the neurologic complications of obesity. Anthocyanins emerge, therefore, as a new class of psychobiotics.
Lastly, these preclinical studies have prompted interest in whether targeting the gut microbiota with antho-
cyanins might be a viable strategy to influence tryptophan availability for kynurenine metabolism and neuroin-
flammatory control within CNS.
Experimental Procedures
Animals. Twenty-four male Wistar rats were randomly divided into four groups (n = 6 per group), as pre-
viously described: (C) standard diet; (C + BE) standard diet + blackberry anthocyanin rich extract; (HF) high-
fat diet; (HF + BE) high-fat diet + blackberry anthocyanin rich extract13,39. Animals were fed ad libitum with 
“standard” (Teklad 2014, Harlan Laboratories, Santiga, Spain) or “high-fat” diets (D1245 Research Diets, New 
Brunswick, USA) for 17 weeks. Blackberry anthocyanin rich extract (BE, 25 mg/kg body weight/day) was 
obtained as previously described13. Briefly, blackberry anthocyanins (Rubus fruticosus) were extracted with 50% 
aqueous ethanol (pH 1.5, acidified with HCl) for 24 h at 22 °C. The solution obtained was filtered (50-μmnylon 
membrane) and concentrated using a rotary evaporator under at 30 °C. The concentrated extract was added to a 
polyamide gel column (mesh 100–120) to remove sugars. The sugar-free anthocyanin extract was freeze-dried 
and stored at −20 °C. BE was dissolved daily in sterile water and embedded in food pellets that animals had daily 
access to. Animal handling and housing protocols followed European Union guidelines (86/609/EEC) for the 
use of experimental animals. The study obtained ethical approval from the Ethical Committee of the Faculty of 
Medicine of University of Porto.
www.nature.com/scientificreports/
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DNA extraction from stool and 16S rRNA sequence analysis. Fresh fecal samples were collected 
directly from the colon of all animals, snap-frozen in liquid nitrogen and stored at −80 °C until further anal-
ysis. Genomic DNA was extracted and purified from stool samples using NZY Tissue gDNA Isolation Kit 
(NZYTech, Lisbon, Portugal) as previously described by Marques et al.23. Firmicutes and Bacteroidetes were 
quantified by real-time PCR as previously described by Marques et al.23. Libraries were prepared following the 
16S Metagenomic Sequencing Library Preparation protocol from illumina (illumina; San Diego, CA, USA). The 
region of interest was captured using the Klidnworth et al. set of primers that covered the hypervariable region 
V3–V4 of the bacterial 16s rRNA40. Samples were pooled and loaded into the illumina MiSeq System and, then, 
sequenced using a 300PE combination according to manufacturer’s specifications.
Raw sequencing reads were merged with PEAR v0.9.6. Amplification primers were trimmed from the 
sequences obtained using the default program settings of cutadapt v1.9.141. Sequencing quality filtering was sub-
sequently applied to isolate the sequences having more than 300 nts with a mean quality score ≥20. Sequences 
were excluded from all downstream analyses. Sequences were also inspected for PCR chimera constructs. The 
resulting sequence reads were clustered into operational taxonomic units (OTU) at 98% similarity, using cd-hit 
program. NCBI database was used to assign a taxonomic classification to each read in the representative set. 
Reads with no hits in the reference sequence collection were classified as “null”. OTUs with a relative abundance 
<1% in all samples were considered non-significant and are not presented. Shannon’s richness index was calcu-
lated using the formula described in42.
Neuroinflammation assessment. As previously described, neuroinflammatory markers were measured 
in the hippocampus of all animals using a predefined cytokine glass-based array (Quantibody Rat Cytokine 
Array; RayBiotech), according to manufacturer’s instructions13.
Fecal LPS quantification. Quantification of LPS was performed using the Chromo-Limulus Amebocyte 
Lysate (Chromo-LAL) reagent (Associates of Cape Cod, Inc., Falmouth, MA, USA). Briefly, 1 mL of sterile 
saline solution (NaCl 0.9%) was added to 100 mg feces, vortexed and centrifuged (10 min, 10000 g, 4 °C) twice. 
Total supernatant (fecal water) was filtered with 0.45 μm filter and then with 0.22 μm filter. Fecal water and 
Chromo-LAL (1:1) were incubated at 37 °C for 20 min and absorbance was read every 10 s at 405 nm.
Fecal and urine metabolome analysis by HPLC/Orbitrap. The fecal water obtained for LPS quanti-
fication was also used for metabolomics experiments. Urine samples were prepared according to the procedure 
described by Marques et al.43. Samples were analyzed by HPLC/Orbitrap according to the method described 
by Fernandes et al.44. Mass spectrometry (MS) data was uploaded into XCMS Online and was processed as a 
multi-group experiment using the default HPLC/Orbitrap parameters in negative mode (fecal samples) or pos-
itive mode (urine samples)45. Isotopes and adducts were annotated using CAMERA and arranged into feature 
groups. Metabolite features were selected to assess the differences between the fecal and urine samples of C, 
C + BE, HF and HF + BE groups. Tryptophan, kynurenine and kynurenic acid (MilliporeSigma, St. Louis, MO, 
USA) were used as standards.
Statistical analysis. Two-way ANOVA was used to determine the main effects of diet (CDe vs HF diet), BE 
supplementation (No BE vs BE) and their interaction. In XCMS online, one-way ANOVA followed by a post hoc 
multi comparison test was used in multi group experiment. To compare the differences between two groups, t-test 
was used. Correlation between variables was established using Spearman’s correlation test. Statistical analyses 
were performed using SPSS Statistics 23 (IBM, USA) software. Differences were considered statistically significant 
when p < 0.05. Principal component analysis (PCoA) was performed in R 3.0.2 (The R Foundation, New Zealand) 
with the RStudio 0.97.310 package. Heatmaps were elaborated using CIMminer platform (https://discover.nci.
nih.gov/cimminer/home.do).
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